Fund profile
Tickers
GNOM
Fund manager
Total assets
$93.07 mm
Liabilities
$36.75 k
Net assets
$93.03 mm
Number of holdings
46.00
GNOM stock data
46 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
CRSP CRISPR Therapeutics AG | 5.47 mm | 81.99 k shares | 5.88 | Common equity | Long | USA |
NTRA Natera Inc | 4.49 mm | 80.18 k shares | 4.82 | Common equity | Long | USA |
A Agilent Technologies Inc. | 3.97 mm | 31.06 k shares | 4.27 | Common equity | Long | USA |
NTLA Intellia Therapeutics Inc | 3.90 mm | 131.73 k shares | 4.20 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 3.80 mm | 97.83 k shares | 4.09 | Common equity | Long | USA |
TXG 10x Genomics Inc - Ordinary Shares | 3.78 mm | 86.75 k shares | 4.06 | Common equity | Long | USA |
CFRXQ CONTRAFECT Corp | 3.69 mm | 435.65 k shares | 3.97 | Common equity | Long | USA |
QGEN Qiagen NV | 3.59 mm | 87.11 k shares | 3.85 | Common equity | Long | USA |
BMRN Biomarin Pharmaceutical Inc. - Registered Shares | 3.58 mm | 39.28 k shares | 3.85 | Common equity | Long | USA |
GENSCRIPT BIOTECH CORP COMMON STOCK
|
3.52 mm | 1.27 mm shares | 3.79 | Common equity | Long | Hong Kong |
ALNY Alnylam Pharmaceuticals Inc | 3.39 mm | 20.14 k shares | 3.64 | Common equity | Long | USA |
BNTX BioNTech SE | 3.39 mm | 33.72 k shares | 3.64 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc | 3.37 mm | 119.90 k shares | 3.62 | Common equity | Long | USA |
VCYT Veracyte Inc | 3.31 mm | 129.27 k shares | 3.56 | Common equity | Long | USA |
TECH Bio-Techne Corp | 3.30 mm | 52.40 k shares | 3.54 | Common equity | Long | USA |
MRNA Moderna Inc | 3.25 mm | 41.83 k shares | 3.49 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals Inc | 3.12 mm | 133.89 k shares | 3.36 | Common equity | Long | USA |
LEGN Legend Biotech Corp | 3.05 mm | 50.19 k shares | 3.28 | Common equity | Long | USA |
ILMN Illumina Inc | 2.87 mm | 28.19 k shares | 3.09 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals Inc. | 2.84 mm | 133.94 k shares | 3.05 | Common equity | Long | USA |
MYGN Myriad Genetics, Inc. | 2.70 mm | 141.32 k shares | 2.90 | Common equity | Long | USA |
SRPT Sarepta Therapeutics Inc | 2.43 mm | 29.93 k shares | 2.62 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals, Inc. | 1.57 mm | 4.42 k shares | 1.68 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 1.57 mm | 20.45 k shares | 1.68 | Common equity | Long | USA |
EDIT Editas Medicine Inc | 1.53 mm | 145.44 k shares | 1.65 | Common equity | Long | USA |
VIR Vir Biotechnology Inc | 1.49 mm | 156.80 k shares | 1.60 | Common equity | Long | USA |
RGNX Regenxbio Inc | 1.39 mm | 71.44 k shares | 1.50 | Common equity | Long | USA |
RNA Avidity Biosciences Inc | 993.87 k | 127.26 k shares | 1.07 | Common equity | Long | USA |
RBC DOMINION SECURITIES INC | 948.19 k | 948.19 k principal | 1.02 | Repurchase agreement | Long | USA |
DAIWA CAPITAL MARKETS AMERICA INC | 948.19 k | 948.19 k principal | 1.02 | Repurchase agreement | Long | USA |
CITIGROUP GLOBAL MARKETS INC | 948.19 k | 948.19 k principal | 1.02 | Repurchase agreement | Long | USA |
FLGT Fulgent Genetics Inc | 941.50 k | 34.14 k shares | 1.01 | Common equity | Long | USA |
HSBC SECURITIES (USA) INC | 929.22 k | 929.22 k principal | 1.00 | Repurchase agreement | Long | USA |
CDNA Caredx Inc | 898.97 k | 92.58 k shares | 0.97 | Common equity | Long | USA |
VERV Verve Therapeutics Inc | 867.94 k | 76.95 k shares | 0.93 | Common equity | Long | USA |
CRBU Caribou Biosciences Inc | 796.16 k | 135.63 k shares | 0.86 | Common equity | Long | USA |
SANA Sana Biotechnology Inc | 714.34 k | 175.95 k shares | 0.77 | Common equity | Long | USA |
BLUE Bluebird bio Inc | 710.84 k | 186.09 k shares | 0.76 | Common equity | Long | USA |
TAKARA BIO INC COMMON STOCK
|
682.24 k | 82.54 k shares | 0.73 | Common equity | Long | Japan |
QURE uniQure N.V. | 514.66 k | 75.91 k shares | 0.55 | Common equity | Long | USA |
ALLO Allogene Therapeutics Inc | 445.35 k | 189.51 k shares | 0.48 | Common equity | Long | USA |
LYEL Lyell Immunopharma Inc | 375.73 k | 217.19 k shares | 0.40 | Common equity | Long | USA |
PSTX Poseida Therapeutics Inc | 301.75 k | 113.01 k shares | 0.32 | Common equity | Long | USA |
DEUTSCHE BANK SECURITIES INC | 261.05 k | 261.05 k principal | 0.28 | Repurchase agreement | Long | USA |
TSVT 2seventy bio Inc | 143.29 k | 78.30 k shares | 0.15 | Common equity | Long | USA |
SCILEX HOLDING CO - RESTRICTED SPECIAL PURPOSE ACQUISITION COMPANIES
|
141.29 k | 226.07 k shares | 0.15 | Common equity | Long | USA |